•  
  •  
  •  
  •  

2025-09-02 22:56:28

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • NDTV Board approves Rights Issue of upto INR 400 Crore
  • Cupid Limited Robust B2B Export Order Book & Encouraging International Order Pipeline
  • PNC Infratech Ltd emerges L1 bidder for AAI tender
  • ITCONS E-Solutions Limited bags contract
  • SDHI & Indian Maritime University sign MoU to launch maritime Centres of Excellence, specialized workforce training programmes

Keywords Selected:  INE068V01023

Stock Report

  • Gland Pharma receives approval for Vasopressin in 5% Dextrose RTU Injection
  • Gland Pharma receives approval for Norepinephrine Bitartrate in 5% Dextrose Injection Bags
  • Gland Pharma receives approval from USFDA for Cangrelor for Injection 50 mg/vial
  • Gland Pharma Ltd receives GMP compliance from Danish Medicines Agency
  • Gland Pharma Ltd receives EIR from US FDA for JNPC Facility, Visakhapatnam
  • Gland Pharma Receives Approval for Angiotensin II Acetate Injection
  • Gland Pharma receives approval from USFDA for Latanoprostene Bunod Opthalmic Solution
  • Gland Pharma receives approval for Acetaminophen Injection
  • USFDA issues Form 483 with 3 observations to Gland Pharma's Sterile APIs unit
  • ANSM Inspection at Cenexi's Fontenay Manufacturing Facility
  • Gland Pharma receives approval for Phytonadione Injection Emulsion
  • Gland Pharma receives approval for Latanoprost Opthalmic Solution, 0.005% (2.5 mL Fill)
  • Surprise USFDA inspection at Gland Pharma Limited's Dundigal Facility
  • Gland Pharma receives Tentative Approval from the USFDA for Latanoprostene Bunod Ophthalmic Solution
  • Srinivas Sadu appointed as Executive Chairman and CEO of Gland Pharma Ltd
  • Gland Pharma receives approval for Edaravone Injection
  • Gland Pharma receives approval for Plerixafor for Injection
  • Gland Pharma receives approval for Cetrorelix Acetate for Injection
  • Gland Pharma receives approval for Eribulin Mesylate Injection
  • Gland Pharma Ltd receives EIR from USFDA for Pashamylaram Facility at Hyderabad
  • Gland Pharma Limited updates on USFDA Pre-Market Inspection at Pashamylaram Facility
  • Gland Pharma Limited receives EIR from USFDA for Dundigal Facility
  • Gland Pharma Ltd announces conclusion of US FDA Inspection at VSEZ Sterile Oncology Facility, Visakhapatnam
  • Gland Pharma Limited - Conclusion of US FDA Inspection at Dundigal Facility, Hyderabad

Latest Post

  • NDTV Board approves Rights Issue of upto INR 400 Crore
  • Cupid Limited Robust B2B Export Order Book & Encouraging International Order Pipeline
  • PNC Infratech Ltd emerges L1 bidder for AAI tender
  • ITCONS E-Solutions Limited bags contract
  • SDHI & Indian Maritime University sign MoU to launch maritime Centres of Excellence, specialized workforce training programmes


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024